Graduate Faculty Directory
Danny A. Benau
Education
- AB, PhD (Boston University)
Title(s)
Interim Director, Biomedical Writing Programs
Faculty Appointments
Associate Professor of Biomedical Writing
Professional Information
Freelance Regulatory Medical Writing
Publications & Presentations
- Abrao EG, Pratt R, Brownstein B, Orlando A, Benau D. Open label study of the methylphenidate transdermal system in children with adhd/extension continuation long-term evaluation. [Clinical Study Report: Protocol N17-021] Noven Pharmaceuticals, Inc. and Shire Pharmaceuticals, Inc. 2005.
- Horowitz Z, Huang YW, Rehrig C, Sundy JS, Alton M, Benau D, Brownstein B, Stouch B. A phase 1 study to evaluate the pharmacokinetic profile, tolerability and safety of intravenously administered Puricase (PEG-uricase). [Clinical Study Report: Protocol CO402] Savient Pharmaceuticals, Inc. 2005.
- Ottery FD, Huang YW, Kramer T, Alton M, Horowitz Z, Benau D, Brownstein M, McCarron T. A randomized, double blind, placebo controlled dose-ranging clinical trail of the efficacy and safety of oxandrolone in increasing repiratory muscle strength of patients with chronic obstructive pulmonary disease-associated weight loss. [Clinical Study Report: Protocol CO221] Savient Pharmaceuticals, Inc. 2005.
- Ottery F, Huang YW, Alton M, Horowitz Z, Benau D, Brownstein M, McCarron T. A randomized, double-blind, placebo-controlled dose-ranging clinical trial to evaluate the safety and efficacy of oxandrolone in the treatment of pressure ulcers in subjects with weight loss. [Clinical Study Report: Protocol CO223] Savient Pharmaceuticals, Inc. 2004.
- Tierney D, Kuzma P, Gray W, Benau D, Brownstein B, Stouch B. Phase III, open label study to evaluate efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer; 120-day update - extension patients. [Clinical Study Report: Protocol 301E] Valera Pharmaceuticals, Inc. 2004.
- June 2005, Chances and challenges: outlook on the future enviornment of medical writers, Drug Information Association Annual Meeting, Washington, DC.
- June 2003, Recruiting pitch for the Professional and Personal Development Special Interest Area Community, Drug Information Association Annual Meeting, San Antonio, TX.
- July 1999, Extending word processing fuctions with macros, Drug Information Association Annual Meeting, Baltimore, MD.
- September 1997, Toolbox approach to incorporating data from various sources, Drug Information Association, Bruges, Belgium.
- February 1997, Interactions between SAS-generated data and word processing programs, PhilaSUG (Philadelphia SAS Users Group), Radnor, PA.
Contact Information
Office:
Glasser Hall
Room # 208
Box # 107
Phone: 215.596.7509
Email: d.benau@usp.edu
